Keyphrases
United States
100%
Chronic Obstructive Pulmonary Disease
100%
Hospitalization
100%
Driving Time
100%
Inhaler
100%
Rurality
100%
Fragmented Care
100%
Time to Care
100%
Monotherapy
23%
Specialty Care
23%
Adjusted Odds Ratio
23%
Veterans Health Administration
23%
Inhaled Corticosteroids
23%
Long-acting muscarinic Antagonist
15%
Long-acting beta-agonists
15%
Primary Care
7%
Acute Exacerbation of COPD (AECOPD)
7%
Race-ethnicity
7%
Level Difference
7%
Geocoding
7%
NCATS
7%
Charlson Comorbidity Index
7%
Evidence-based Care
7%
Rural Residence
7%
Residence Time
7%
Logistic Regression Model
7%
Rural Residents
7%
Multiple Providers
7%
Multivariable Logistic Regression
7%
Patient-level
7%
Short-acting
7%
Area Deprivation Index
7%
Retrospective Cohort Analysis
7%
Medicine and Dentistry
Cohort Analysis
100%
Drive
100%
Chronic Obstructive Pulmonary Disease
100%
Monotherapy
75%
Odds Ratio
75%
Veterans Health
75%
Muscarinic Antagonist
50%
Beta Adrenergic Receptor Stimulating Agent
50%
Disease Exacerbation
25%
Primary Health Care
25%
Logistic Regression Analysis
25%
Charlson Comorbidity Index
25%
Nursing and Health Professions
Practice Guideline
100%
Obstructive Lung Disease
100%
Inhaler
100%
Cohort Analysis
100%
Odds Ratio
23%
Health Care Management
23%
Monotherapy
23%
Muscarinic Receptor Blocking Agent
15%
Beta-Adrenergic Agonist
15%
Primary Medical Care
7%
Disease Exacerbation
7%
Logistic Regression Analysis
7%
Charlson Comorbidity Index
7%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Cohort Study
100%
Monotherapy
75%
Muscarinic Receptor Blocking Agent
50%
Beta Adrenergic Receptor Stimulating Agent
50%
Disease Exacerbation
25%
Comorbidity
25%